Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product & Services
3.2. Snippet by Technology
3.3. Snippet by Indication
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Advancing Novel Frameworks for Companion Diagnostics
4.1.1.2. Growing Partnerships for Advance Next-Generation Sequencing Companion Diagnostics
4.1.2. Restraints
4.1.2.1. Challenges Associated with Companion Diagnostic Development
4.1.3. Opportunity
4.1.3.1. Collaboration and Innovation Among Market Players
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. By Product & Services
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services
8.1.2. Market Attractiveness Index, By Product & Services
8.2. Assays*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Kits & Reagents
8.4. Software & Services
9. By Technology
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.1.2. Market Attractiveness Index, By Technology
9.2. Immunohistochemistry (IHC)*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Polymerase Chain Reaction (PCR)
9.4. In-situ Hybridization (ISH)
9.5. Next-generation Sequencing
9.6. Others
10. By Indication
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.1.2. Market Attractiveness Index, By Indication
10.2. Cardiovascular*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Neurological Diseases
10.4. Cancer
10.4.1. Breast Cancer
10.4.2. Lung Cancer
10.4.3. Colorectal Cancer
10.4.4. Melanoma
10.4.5. Gastric Cancer
10.4.6. Others
10.5. Inflammation and Autoimmune Diseases
10.6. Others
11. By End User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Pharmaceutical & Biopharmaceutical Companies*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Contract Research Organizations
11.4. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.2.7.1. U.S.
12.2.7.2. Canada
12.2.7.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.3.7.1. Germany
12.3.7.2. U.K.
12.3.7.3. France
12.3.7.4. Italy
12.3.7.5. Spain
12.3.7.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.4.7.1. Brazil
12.4.7.2. Argentina
12.4.7.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.5.7.1. China
12.5.7.2. India
12.5.7.3. Japan
12.5.7.4. Australia
12.5.7.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Product Benchmarking
13.3. Company Share Analysis
13.4. Key Developments and Strategies
14. Company Profiles
14.1. F. Hoffmann-La Roche Ltd. *
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Agilent Technologies, Inc.
14.3. Qiagen N.V.
14.4. Thermo Fisher Scientific, Inc.
14.5. Abbott Laboratories, Inc.
14.6. Biomerieux SA
14.7. Siemens Healthcare
14.8. Thermo Fisher Scientific Inc.
14.9. Danaher Corporation (Beckman Coulter Inc.)
14.10. Guardant Health
14.11. Illumina Inc.
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us